Comparative Study Between IVI of Ranibizumab With and Without Prior ACP in Patients With DME Using OCT-A
Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to to evaluate the changes in retinal microvasculature
secondary to intra-ocular pressure changes post intra-vitreal injection in patients with
diabetic macular oedema highlighting the effect of prior anterior chamber paracentesis on
such changes if present .
The main question[s]it aims to answer are:
•[is there any effect of post intra-vitreal injection IOP spikes on retinal
microvasculature?] •[is there any effect of Prior Anterior Chamber Paracentesis?]
Participants in group A will be subjected to an identified approved treatment( intra-vitreal
injection)& Participants in group B will be subjected to a prior ACP with the intra-vitreal
injection . ]